Study on the different expression of molecular markers between cardiac cancer and distal gastric cancer and their correlations with clinicopathological features

Dig Surg. 2009;26(5):384-91. doi: 10.1159/000226766. Epub 2009 Nov 13.

Abstract

Background and aim: Currently, few studies have reported the different expression of molecular markers between distal gastric cancer and cardiac cancer. Here, we sought to make an investigation about it by a retrospective analysis.

Methods: The expression of 8 proteins, including epidermal growth factor receptor, glutathione S-transferase pi (GST-pi), cyclin D1, Neu/Her-2, C-myc, p53, p27 and p21, were evaluated in 110 cases with cardiac cancer and 101 cases with distal gastric cancer who underwent curative surgery at the Cancer Hospital, Fudan University, in 2005 by immunohistochemistry method.

Results: The TNM stage, differentiation grade, invasion depth and lymph node metastasis were significantly different between cardiac cancer and distal gastric cancer. p21 (p = 0.034), Neu (p = 0.017), and GST-pi (p = 0.003) were expressed in relatively higher levels in cardiac cancer than in distal gastric cancer. Furthermore, the clinical pathological parameters were significantly correlated with the expression of molecules mentioned above.

Conclusion: Different molecular mechanisms may be involved in the tumorigenesis and development of cardiac cancer and distal gastric cancer.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / metabolism*
  • Cardia / metabolism*
  • Cardia / pathology
  • Cyclin D1 / metabolism
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • Cyclin-Dependent Kinase Inhibitor p27 / metabolism
  • DNA-Binding Proteins / metabolism
  • ErbB Receptors / metabolism
  • Female
  • Glutathione S-Transferase pi / metabolism
  • Humans
  • Male
  • Middle Aged
  • Neuraminidase / metabolism
  • Retrospective Studies
  • Stomach Neoplasms / metabolism*
  • Stomach Neoplasms / mortality
  • Stomach Neoplasms / pathology
  • Survival Rate
  • Transcription Factors / metabolism
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • DNA-Binding Proteins
  • MYCBP protein, human
  • Transcription Factors
  • Cyclin D1
  • Cyclin-Dependent Kinase Inhibitor p27
  • Glutathione S-Transferase pi
  • ErbB Receptors
  • NEU2 protein, human
  • Neuraminidase